March 7, 2023
Václav Potěšil, Founder and Chief Business Officer, interviewed by TechRound
Vaclav joined TechRound editor to talk about how Optellum has evolved since being founded to becoming the leader in AI diagnosis.
My aunt was diagnosed and passed away from lung cancer after coughing up blood, having never smoked a cigarette. This experience contributed to me being involved in computer vision research applied to lung cancer – way before AI in healthcare became popular (and even ready for clinical use).
Václav Potěšil
Read the interview here.
Recent posts
August 13, 2026 / News & Press, Partnerships
Coreline Soft and Optellum announce intent to collaborate to advance AI...Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform
Read more
June 15, 2026 / News & Press, Partnerships
Optellum Awarded NIHR Funding for Multi-Site NHS Pilot Study for Accelerated...Optellum announced it has been awarded funding for a competitive programme, Invention for Innovation (i4i), focused on transformative and disruptive innovations to reduce waiting...
Read more
June 10, 2026 / News & Press, Partnerships
Tanner Health and Healthliant Ventures Partner with Optellum to Bring AI...Tanner Health and Healthliant Ventures announce the launch of Optellum’s Virtual Nodule Clinic® (VNC), an artificial intelligence (AI) platform designed to assist care teams...
Read more
Optellum is trusted by industry & academic leaders
Certification
Redefining early intervention of lung disease
starting with one of the deadliest, lung cancer
Contact us